436 related articles for article (PubMed ID: 17410813)
1. Oncologist-patient discussion of adjuvant hormonal therapy in breast cancer: results of a linguistic study focusing on adherence and persistence to therapy.
Davidson B; Vogel V; Wickerham L
J Support Oncol; 2007 Mar; 5(3):139-43. PubMed ID: 17410813
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant treatment recommendations in older women with breast cancer: a survey of oncologists.
Hurria A; Naeim A; Elkin E; Limaye S; Grover A; Hudis C; Pearce C; Robson M
Crit Rev Oncol Hematol; 2007 Mar; 61(3):255-60. PubMed ID: 17098441
[TBL] [Abstract][Full Text] [Related]
3. Improving in-office discussion of chronic obstructive pulmonary disease: results and recommendations from an in-office linguistic study in chronic obstructive pulmonary disease.
Nelson M; Hamilton HE
Am J Med; 2007 Aug; 120(8 Suppl 1):S28-32. PubMed ID: 17678941
[TBL] [Abstract][Full Text] [Related]
4. Improving compliance and persistence to adjuvant tamoxifen and aromatase inhibitor therapy.
Hadji P
Crit Rev Oncol Hematol; 2010 Feb; 73(2):156-66. PubMed ID: 19299162
[TBL] [Abstract][Full Text] [Related]
5. Surveillance testing among survivors of early-stage breast cancer.
Keating NL; Landrum MB; Guadagnoli E; Winer EP; Ayanian JZ
J Clin Oncol; 2007 Mar; 25(9):1074-81. PubMed ID: 17369571
[TBL] [Abstract][Full Text] [Related]
6. Improving outcomes in early-stage breast cancer.
Glück S; Mamounas T
Oncology (Williston Park); 2010 Oct; 24(11 Suppl 4):1-15. PubMed ID: 21284351
[TBL] [Abstract][Full Text] [Related]
7. Treatment trends and factors associated with survival in T1aN0 and T1bN0 breast cancer patients.
Kennedy T; Stewart AK; Bilimoria KY; Patel-Parekh L; Sener SF; Winchester DP
Ann Surg Oncol; 2007 Oct; 14(10):2918-27. PubMed ID: 17638060
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of the randomized Stockholm trial on adjuvant tamoxifen among postmenopausal patients with early stage breast cancer.
Rutqvist LE; Johansson H;
Acta Oncol; 2007; 46(2):133-45. PubMed ID: 17453361
[TBL] [Abstract][Full Text] [Related]
9. Adherence to oral endocrine therapy for breast cancer: a nursing perspective.
Miaskowski C; Shockney L; Chlebowski RT
Clin J Oncol Nurs; 2008 Apr; 12(2):213-21. PubMed ID: 18390458
[TBL] [Abstract][Full Text] [Related]
10. Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy.
Cella D; Fallowfield LJ
Breast Cancer Res Treat; 2008 Jan; 107(2):167-80. PubMed ID: 17876703
[TBL] [Abstract][Full Text] [Related]
11. The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study.
Stewart A; Collins B; Mackenzie J; Tomiak E; Verma S; Bielajew C
Psychooncology; 2008 Feb; 17(2):122-30. PubMed ID: 17518411
[TBL] [Abstract][Full Text] [Related]
12. Compliance and persistence of endocrine adjuvant breast cancer therapy.
Güth U; Myrick ME; Kilic N; Eppenberger-Castori S; Schmid SM
Breast Cancer Res Treat; 2012 Jan; 131(2):491-9. PubMed ID: 21976056
[TBL] [Abstract][Full Text] [Related]
13. Impact of providing audiotapes of primary adjuvant treatment consultations to women with breast cancer: a multisite, randomized, controlled trial.
Hack TF; Pickles T; Bultz BD; Ruether JD; Weir LM; Degner LF; Mackey JR
J Clin Oncol; 2003 Nov; 21(22):4138-44. PubMed ID: 14615442
[TBL] [Abstract][Full Text] [Related]
14. Sequential therapy with tamoxifen and aromatase inhibitors in early-stage postmenopausal breast cancer: a review of the evidence.
Litsas G
Oncol Nurs Forum; 2008 Jul; 35(4):714-21. PubMed ID: 18591176
[TBL] [Abstract][Full Text] [Related]
15. Doctor-patient communication, health-related beliefs, and adherence in glaucoma results from the Glaucoma Adherence and Persistency Study.
Friedman DS; Hahn SR; Gelb L; Tan J; Shah SN; Kim EE; Zimmerman TJ; Quigley HA
Ophthalmology; 2008 Aug; 115(8):1320-7, 1327.e1-3. PubMed ID: 18321582
[TBL] [Abstract][Full Text] [Related]
16. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.
Ellis MJ; Tao Y; Luo J; A'Hern R; Evans DB; Bhatnagar AS; Chaudri Ross HA; von Kameke A; Miller WR; Smith I; Eiermann W; Dowsett M
J Natl Cancer Inst; 2008 Oct; 100(19):1380-8. PubMed ID: 18812550
[TBL] [Abstract][Full Text] [Related]
17. Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer.
Krzyzanowska MK; Regan MM; Powell M; Earle CC; Weeks JC
J Am Coll Surg; 2009 Feb; 208(2):202-9. PubMed ID: 19228531
[TBL] [Abstract][Full Text] [Related]
18. Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen.
Kennecke H; McArthur H; Olivotto IA; Speers C; Bajdik C; Chia SK; Ellard S; Norris B; Hayes M; Barnett J; Gelmon KA
Cancer; 2008 Apr; 112(7):1437-44. PubMed ID: 18286526
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of a letter notification program for women with early-stage breast cancer eligible for extended adjuvant letrozole.
McArthur HL; Gelmon KA; Olivotto IA; Speers CH; Ellard SL; O'Reilly SE; Kennecke HF
J Clin Oncol; 2009 Mar; 27(9):1388-93. PubMed ID: 19237634
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors of early distant recurrence in hormone receptor-positive, postmenopausal breast cancer patients receiving adjuvant tamoxifen therapy: results of a retrospective analysis.
Debled M; MacGrogan G; Brouste V; Mathoulin-Pelissier S; Durand M; Mauriac L
Cancer; 2007 Jun; 109(11):2197-204. PubMed ID: 17450590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
